Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Oncológico Gallego (GOG) is a prominent Spanish cooperative research group focused on advancing clinical oncology through multicenter trials and scientific collaboration. Based in Galicia, the organization unites oncologists and researchers from across the regional healthcare system to improve cancer treatment standards and patient outcomes. GOG specializes in the design and execution of Phase II and III clinical trials, often collaborating with international research networks and the pharmaceutical industry. Their work spans a wide range of malignancies, with significant contributions to breast, lung, and gastrointestinal cancer research. By fostering a multidisciplinary approach, GOG ensures that patients in the Galicia region have access to cutting-edge therapies and innovative clinical protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Oncológico Gallego.